135 related articles for article (PubMed ID: 3865476)
1. Dissociation between kallikrein and aldosterone in Cushing's disease with periodic hormonogenesis.
Overlack A; Higuchi M; Kolloch R; Müller HM; Stumpe KO; Schweikert HU
Acta Endocrinol (Copenh); 1985 Nov; 110(3):296-301. PubMed ID: 3865476
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of aldosterone on kallikrein, prostaglandin E2 and sodium in rats.
Yasujima M; Abe K; Tanno M; Kohzuki M; Kanazawa M; Omata K; Kasai Y; Sato M; Takeuchi K; Itoh S
Tohoku J Exp Med; 1987 Aug; 152(4):351-62. PubMed ID: 3477885
[TBL] [Abstract][Full Text] [Related]
3. Effect of aldosterone on urinary kallikrein and prostaglandin excretion in the rat.
Fejes-Tóth G; Náray-Fejes-Tóth A
J Physiol; 1984 Sep; 354():79-88. PubMed ID: 6592330
[TBL] [Abstract][Full Text] [Related]
4. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K
Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
[TBL] [Abstract][Full Text] [Related]
5. Urinary kallikrein, aldosterone, prostaglandin E2, sodium, potassium, and urinary volume in normal man-interrelations and day to day variation.
Ohman KP; Karlberg BE
Acta Med Scand Suppl; 1983; 677():30-5. PubMed ID: 6584001
[No Abstract] [Full Text] [Related]
6. The prostaglandin and kallikrein-kinin systems in mineralocorticoid escape.
Zipser RD; Zia P; Stone RA; Horton R
J Clin Endocrinol Metab; 1978 Nov; 47(5):996-1001. PubMed ID: 263798
[TBL] [Abstract][Full Text] [Related]
7. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
8. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
Nasjletti A; McGiff JC; Colina-Chourio J
Circ Res; 1978 Nov; 43(5):799-807. PubMed ID: 309362
[TBL] [Abstract][Full Text] [Related]
9. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
[TBL] [Abstract][Full Text] [Related]
10. Increased excretion of kallikrein during dexamethasone administration in normal man on low and normal salt intake.
López JM; Arteaga E; Rodriguez JA; Croxatto H
Clin Sci (Lond); 1983 Nov; 65(5):487-90. PubMed ID: 6555065
[TBL] [Abstract][Full Text] [Related]
11. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
Handa M; Kondo K; Suzuki H; Saruta T
Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
[TBL] [Abstract][Full Text] [Related]
12. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
[TBL] [Abstract][Full Text] [Related]
13. Effect of urinary pH and urine flow rate on prostaglandin E2 and kallikrein excretion by the conscious dog.
Filep J; Földes-Filep E
J Physiol; 1987 Feb; 383():1-8. PubMed ID: 2821232
[TBL] [Abstract][Full Text] [Related]
14. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
[TBL] [Abstract][Full Text] [Related]
15. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid escape during kallikrein inhibition.
Overlack A; Bäcker-Kreutz E; Ressel C; Müller HM; Kolloch R; Stumpe KO
Clin Sci (Lond); 1986 Jan; 70(1):13-7. PubMed ID: 2417776
[TBL] [Abstract][Full Text] [Related]
17. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
[TBL] [Abstract][Full Text] [Related]
18. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
[TBL] [Abstract][Full Text] [Related]
19. Relationship of urinary kallikrein excretion to renal water and sodium excretion.
Ueno M; Kawasaki T; Uezono K; Omae T; Matsuoka M
Metabolism; 1983 May; 32(5):433-7. PubMed ID: 6551657
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
Favre L; Jornot L; Riondel A; Vallotton M
Clin Exp Hypertens A; 1985-1986; 7(12):1663-79. PubMed ID: 3869481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
